Wealth Watch Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$579K Buy
483
+57
+13% +$58.2K 0.19% 67
2026
Q1
$392K Buy
426
+34
+9% +$34.5K 0.16% 73
2025
Q4
$421K Buy
392
+148
+61% +$142K 0.16% 72
2025
Q3
$186K Sell
244
-253
-51% -$188K 0.08% 94
2025
Q2
$212K Buy
+497
New +$386K 0.12% 96

Other funds holding LLY

Wealth Watch Advisors's LLY Position: Q2 2026 in Review

Wealth Watch Advisors increased its Eli Lilly (LLY) stake by 13% in Q2 2026, buying an estimated $58.2K and bringing the position to 483 shares worth $579K. The position accounts for 0.19% of the portfolio, ranked #67.

Wealth Watch Advisors first reported a position in LLY in Q2 2025 and has held it in 5 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Wealth Watch Advisors held 483 shares of Eli Lilly worth $579K as of Q2 2026.
  • Wealth Watch Advisors bought 57 Eli Lilly shares in Q2 2026, an estimated $58.2K.
  • Eli Lilly made up 0.19% of Wealth Watch Advisors's portfolio in Q2 2026, its #67 holding.
  • Wealth Watch Advisors first reported a position in Eli Lilly in Q2 2025 and has held it in 5 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Wealth Watch Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.